EUVIMEDEUVIMED entdecken
Crossref

Association Study Between DRD2, DRD3 Genetic Polymorphisms and Adverse Reactions in Chinese Patients on Amisulpride Treatment

Kankan Qu, Yanan He, Zhongdong Zhang, Yeli Cao, Qiyun Qin, Zhenhe Zhou, Lili Zhen

Pharmacopsychiatry · 01.11.2024 · 57 (06) · 283-289

DOI: 10.1055/a-2375-3859 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacopsychiatry, erschienen am 01.11.2024. Verfasst von Kankan Qu und 6 weiteren Autor:innen. Beteiligte Einrichtung: The affiliated Mental Health Center of Jiangnan University, Wuxi Central Rehabilitation Hospital, Wuxi, Jiangsu, China. Hauptthemen laut MEDLINE: Amisulpride, Antipsychotic Agents, Polymorphism, Single Nucleotide, Receptors, Dopamine D2. Die Arbeit nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To determine if the cardiac function and “endocrinium” of Chinese patients are associated with dopamine D2 (DRD2) (rs6276) and DRD3 (rs6280, rs963468) genetic polymorphisms when treated with amisulpride.

Methods

This study enrolled 148 patients with schizophrenia who took amisulpride orally for 8 weeks. DRD2 (rs6276) and DRD3 (rs6280, rs963468) genetic polymorphisms were detected with TaqMan-MGB allelic discrimination.

Results

Analysis by multivariate covariance analysis (MANCOVA) showed that after adjusting for age, gender, and the baseline level, the increase in the level of aspartate aminotransferase (AST) and creatine kinase (CK) in the rs6276 AG group was higher than that in the AA and GG groups. Similarly, the changed estradiol (E2) level in rs6276 GG and rs963468 GG groups was higher than that in the other two groups. Adjusting for covariates, the increased triglyceride (TG) level in rs6276 GG and rs963468 GG groups was the highest among their different genotype groups. The increase in the level of “AST” in the rs6280 TT group was higher than that in the CC and CT groups upon adjusting for covariates. Similarly, MANCOVA showed that the increase in the level of “CK” in the rs6280 CT group was higher than that in the CC and CT groups. Besides, the increased level of “PRL” in the rs6280 CC group and rs963468 GG group was higher than that in their other two genotypes groups.

Conclusion

DRD2 (rs6276) and DRD3 (rs6280, rs963468) polymorphisms can affect amisulpride tolerability since they are associated with the observed adverse reactions, including cardiac dysfunction and endocrine disorders in Chinese patients with schizophrenia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AmisulprideAntipsychotic AgentsPolymorphism, Single NucleotideReceptors, Dopamine D2Receptors, Dopamine D3SchizophreniaAdultFemaleHumansMaleMiddle AgedYoung AdultAspartate AminotransferasesCreatine KinaseEast Asian PeopleEstradiolGenetic Association StudiesGenotypeSulpirideTriglycerides

Substanzen

AmisulprideAntipsychotic AgentsAspartate AminotransferasesCreatine KinaseDRD2 protein, humanDRD3 protein, humanEstradiolReceptors, Dopamine D2Receptors, Dopamine D3Sulpiride

Autor:innen und Institutionen

  • The affiliated Mental Health Center of Jiangnan University, Wuxi Central Rehabilitation Hospital, Wuxi, Jiangsu, China.
  • Genenexus Technology Corporation, Shanghai, China.

Zitieren

APA

Qu, K., He, Y., Zhang, Z., Cao, Y., Qin, Q., Zhou, Z., & Zhen, L. (2024). Association Study Between DRD2, DRD3 Genetic Polymorphisms and Adverse Reactions in Chinese Patients on Amisulpride Treatment. Pharmacopsychiatry, 57(06), 283-289. https://doi.org/10.1055/a-2375-3859

Vancouver

Qu K, He Y, Zhang Z, Cao Y, Qin Q, Zhou Z, et al. Association Study Between DRD2, DRD3 Genetic Polymorphisms and Adverse Reactions in Chinese Patients on Amisulpride Treatment. Pharmacopsychiatry. 2024;57(06):283-289. doi:10.1055/a-2375-3859

BibTeX
@article{Qu2024,
  author = {Qu, Kankan and He, Yanan and Zhang, Zhongdong and Cao, Yeli and Qin, Qiyun and Zhou, Zhenhe and Zhen, Lili},
  title = {Association Study Between DRD2, DRD3 Genetic Polymorphisms and Adverse Reactions in Chinese Patients on Amisulpride Treatment},
  journal = {Pharmacopsychiatry},
  year = {2024},
  volume = {57},
  number = {06},
  pages = {283--289},
  doi = {10.1055/a-2375-3859}
}
Kostenlos starten →